What this study is
This clinical trial tests two different physical therapy and relaxation interventions, one in-person and at-home called Resiliency and Operative Success for Adults Receiving Lung Cancer Surgery (ROAR-LCS) and one virtually called BeFitMe. These programs that take place before and after standard of care lung cancer surgery, called prehabilitation programs, promote resiliency and patient outcomes (operative success) for adults receiving lung cancer surgery. Lung cancers occur in the chest and often cause symptoms for patients. Poor physical performance and negative mood are two risk factors for a decline in functional status after surgery. Physical therapy and relaxation interventions (i.e. progressive muscle relaxation) are two such interventions that may improve physical and emotional recovery including a potential shortened hospital stay for patients receiving surgery for lung cancer. Starting these intervention programs early alongside cancer treatment can improve symptoms, improve functional status and quality of life, help with emotional needs of patients, improve recovery time, and may even prolong life. ROAR-LCS and BeFitMe may promote resiliency and operative success for adults receiving lung cancer surgery.
What's being tested
- Biospecimen Collection
Intervention · PROCEDURE
Undergo blood sample collection
- Exercise Intervention
Intervention · OTHER
Complete exercises at home
- Exercise Intervention
Intervention · OTHER
Receive portable exercise peddler and resistance bands
- Exercise Intervention
Intervention · OTHER
Complete assigned exercises
- Internet-Based Intervention
Intervention · OTHER
Receive access to the BeFitMe application
- Physical Therapy
Intervention · PROCEDURE
Complete physical therapy sessions
- Relaxation Technique
Intervention · BEHAVIORAL
Complete progressive muscle relaxation
- Survey Administration
Intervention · OTHER
Ancillary studies
- Text Message-Based Navigation Intervention
Intervention · OTHER
Receive motivational text messages
Study details
- Official title
- LiveWellLung: A Prehabilitation Intervention Program to Promote Resiliency and Operative Success Among Adults Receiving Lung Cancer Surgery (ROAR-LCS) With Biospecimen Collection
- Sponsor
- Ohio State University Comprehensive Cancer Center
- Conditions
- Resectable Lung Non-Small Cell Carcinoma
- Enrolling
- 30 people
- Starts
- 2026-07-29
- Est. completion
- 2027-06-30
- Design
- Open-label, non-randomized, parallel groups
- Record
- View on ClinicalTrials.gov ↗
Who can join
Age 18 Years and overSex ALLHealthy volunteers Not acceptedYou may qualify if
- Age ≥ 18 years
- Diagnosed with: potentially resectable non small cell lung cancer (NSCLC) stage (9th edition: IB-IIIB)
- Intent to receive surgery following neoadjuvant systemic therapy from the Ohio State University Comprehensive Cancer Center (OSUCCC) Thoracic Oncology Clinic
- Patients who are at least 6 weeks out of the surgery date are eligible to participate
- Willingness to participate and adhere to the study intervention program
- Ability to understand and willingness to sign an informed consent document
You can't join if
- Prisoners are excluded from participation
- There is NO exclusion criteria pertaining to Eastern Cooperative Oncology Group (ECOG) performance status, laboratory values, or prior cancer diagnoses
- Patients already enrolled on a therapeutic clinical trial will be excluded from this study as to not confound any exploratory outcomes associated with this trial and/or any clinical trials evaluating novel anti-cancer therapies unless granted permission by the local site principal investigator (PI)
Sign in and we'll check these against your records.Full criteria on ClinicalTrials.gov ↗
Loading treatment details…
Study locations (1)
1 openOhio State University Comprehensive Cancer Center
Columbus, Ohio, United States
- Carolyn J. Presley, MD · Contact614-293-6453carolyn.presley@osumc.edu
- Carolyn J. Presley, MD · Principal investigator
Recruiting
Study team
Sponsor
Ohio State University Comprehensive Cancer Center
Study ID OSU-24288
Principal investigator
Carolyn J Presley, MD
Ohio State University Comprehensive Cancer Center
CONTACT
The Ohio State University Comprehensive Cancer Center
Frequently asked questions
The sponsor hasn't published answers to common questions for this trial.